United States v. Graham

UNITED STATES OF AMERICA v. GREGORY GRAHAM

CRIMINAL No. 09-602-(12)

United States District Court, E.D. Pennsylvania

August 23, 2021

MEMORANDUM

C Darnell Jones, II Judge

I. INTRODUCTION

Since the first cases of an unknown respiratory illness were reported in December 2019, ^[1] a localized outbreak of coronavirus disease 2019 (“COVID-19”) quickly evolved into a global pandemic, causing a public health emergency of international concern. As of this writing, the World Health Organization has reported over 211 million confirmed cases of COVID-19 globally, including more than 4.4 million deaths.^[2] In the United States alone, total reported cases now exceed 37 million, and deaths surpass 628, 000.^[3] In the context of this ongoing public health emergency, Gregory Graham has filed a motion requesting compassionate release from prison for “extraordinary and compelling reasons” under 18 U.S.C. § 3582(c)(1)(A)(i). For the reasons set forth below, Mr. Graham's motion must be denied.

II. FACTUAL AND PROCEDURAL BACKGROUND

A. Underlying Criminal Conduct

Mr. Graham's conviction in this matter stems from his involvement in a violent drug conspiracy based in Darby, Pennsylvania. The group called themselves the Third Street Gang (“TSG”), among other names. Members of the TSG committed numerous acts of violence in furtherance of their conspiracy, as set forth in the Government's Response in Opposition to Mr. Graham's motion. See Gov't Resp. (ECF No. 997) at 2. Mr. Graham directly contributed to that violence when he and an accomplice conspired to kill a man “following a dispute about a stolen gun.” Id. In connection with that crime, Mr. Graham pled “guilty to third-degree murder, and was sentenced to 10 to 20 years' imprisonment in state custody.” Id. at 3. “Ultimately, [Mr. Graham] and other TSG members were federally indicted for their drug dealing activities.” Id. In the instant matter, Mr. Graham was charged with and pled guilty to: (i) one count of conspiracy to distribute 280 grams or more of crack cocaine, in violation of 21 U.S.C. §§ 846, 841(a)(1), (b)(1)(A); (ii) one count of distribution of crack cocaine, in violation of 21 U.S.C. § 841(b)(1)(C); and (iii) one count of distribution of cocaine base within 1, 000 feet of a school, in violation of 21 U.S.C. §§ 860 & 841(b)(1)(C).

On May 8, 2012, this Court sentenced Mr. Graham to 180 months' incarceration, to be followed by 6 years of supervised release. See Amended Judgment (ECF No. 846) at 2-3. As of this writing, he is serving his sentence at FCI Petersburg (Medium) and is scheduled to be released from federal prison on February 16, 2025.^[4]

B. COVID-19 in Correctional and Detention Facilities

“Correctional and detention facilities present unique challenges for control of COVID-19 transmission among incarcerated/detained persons and staff. According to public health experts, incarcerated individuals are at special risk of infection, given their living situations, and may also be less able to participate in proactive measures to keep themselves safe; infection control is challenging in these settings.” United States v. Wilson, No. 14-cr-209, 2020 WL 1975082, at *2 (E.D. Pa. Apr. 24, 2020) (internal quotation marks, alterations, and footnotes omitted). Since the outbreak of the pandemic, the Bureau of Prisons (“BOP”) “has implemented a number of protocols to protect the inmate population and staff from COVID-19.” United States v. Stevens, 454 F.Supp.3d 472, 476 (E.D. Pa. 2020).

Presently, BOP operations are governed by Phase Nine of the Action Plan. The current modified operations plan permits only limited group gathering and social distancing has largely been suspended. BOP has limited the movement of inmates and detainees among its facilities. Moreover, official staff travel has been suspended, as has most in-person staff training. BOP is endeavoring to regularly issue face masks to all staff and inmates, and strongly encourages masks to be worn in public areas where social distancing cannot be achieved.

Inmates who travel outside of a BOP institution, such as for court appearances, are to be quarantined upon their return. Newly admitted inmates are screened for COVID-19 exposure risk factors and symptoms. Asymptomatic inmates are placed in quarantine for at least 14 days or until cleared by medical staff. Symptomatic inmates are placed in medical isolation until they test negative for COVID-19 or are cleared by medical staff as meeting the CDC criteria for release from isolation. The Program Review Division will conduct unannounced site visits to ensure compliance with the Health Services Division and the CDC's guidance.

United States v. Ortiz Cabrera, No. 18-cr-304, 2021 WL 411502, at *2 (E.D. Pa. Feb. 5, 2021). At FCI Petersburg (Medium), where Mr. Graham is incarcerated, there are currently no confirmed, active case of COVID-19 among either the inmate population or prison staff. See COVID-19 Cases, FEDERAL BUREAU OF PRISONS, https://www.bop.gov/coronavirus/ (last visited Aug. 23, 2021).

C. Mr. Graham's Request for Compassionate Release

Mr. Graham filed a motion pursuant to 18 U.S.C. § 3582(c)(1)(A)(i), requesting compassionate release on the grounds that his history of smoking places him at high risk for complications arising from potential infection with COVID-19 while incarcerated. Br. in Supp. of Mot. for Release (ECF No. 988) at 1. The government filed a Response in Opposition to Mr. Graham's Motion, and, on August 2, 2021, filed a Supplemental Response in Opposition to the Motion informing the Court that Mr. Graham was offered the Pfizer COVID-19 vaccine on March 18, 2021-which he refused. (ECF Nos. 997 & 1008.) Mr. Graham's Motion is thus ripe for the Court's review.

III. LEGAL STANDARDS

“‘A judgment of conviction that includes a sentence of imprisonment constitutes a final judgment' and may not be modified by a district court except in limited circumstances.” Dillon v. United States, 560 U.S. 817, 824 (2010) (quoting 18 U.S.C. § 3582(b)); see also In re Morris, 345 Fed.Appx. 796, 797 (3d Cir. 2009) (“Once a term of imprisonment has been imposed, a district court has the authority to modify it only in limited circumstances.”). One such exception is set forth in 18 U.S.C. § 3582(c)(1)(A), which provides for what is commonly referred to as “compassionate release.” “As amended by the recently enacted First Step Act, § 3582(c)(1)(A) empowers a district court to modify a term of imprisonment on a defendant's motion after the defendant has exhausted his administrative remedies.” United States v. Moldover, No. 14-637, 2020 WL 6731111, at *5 (E.D. Pa. Nov. 13, 2020).^[5] Under § 3582(c)(1)(A)(i), a court may reduce an inmate's term of imprisonment only if the following conditions are met: (1) “the Court must find that extraordinary and compelling reasons warrant such a reduction”; (2) “any reduction granted by the Court must be consistent with any applicable policy statements issued by the Sentencing Commission”; and (3) “the proposed reduction must be consistent with the sentencing factors outlined in 18 U.S.C. § 3553(a).” United States v. Brown, No. 13-176-05, 2020 WL 2615616, at *1 (E.D. Pa. May 22, 2020) (internal quotation marks omitted).

“Although Congress has not defined the term ‘extraordinary and compelling,' the Sentencing Commission has issued an application note to its relevant policy statement which provides guidance for defining the conjunctive term.” United States v. Ortiz Cabrera, No. 18-304-01, 2021 WL 411502, at *3 (E.D. Pa. Feb. 5, 2021). As relevant here, Application Note 1 to Section 1B1.13 of the Sentencing Guidelines instructs that an “extraordinary and compelling” reason would be presented where a defendant is “suffering from a serious physical or mental condition . . . that substantially diminishes the ability of the defendant to provide self-care within the environment of a correctional facility and from which he or she is not expected to recover.” “In general, however, ‘[i]n the context of the current global pandemic, [c]ourts around the country have [only] granted compassionate release where the defendant suffers from a serious condition that increases the likelihood of severe consequences from COVID-19.'” Moldover, 2020 WL 6731111, at *7 (quoting United States v. Sommerville, 463 F.Supp.3d 585, 596 (W.D. Pa. 2020)).

IV. DISCUSSION

Mr Graham has not shown that extraordinary and compelling reasons justify his release, as he was offered a vaccine protective against COVID-19, yet he refused to be vaccinated. See Gov't Supp'l Resp. (ECF No. 1008) at 1. The government has submitted that Mr. Graham has no known medical contraindication for the vaccine, and Mr. Graham has not claimed otherwise. Id. The U.S. Food and Drug Administration approved the Pfizer vaccine “for emergency use based on its conclusion that, in extensive testing, the vaccine was 95% effective in preventing COVID-19 infection, including in participants with medical comorbidities associated with high risk of severe COVID-19 disease.” Id. at 2 (citing FDA Decision Memorandum). Accordingly, the overwhelming majority of courts to consider the issue have concluded that the risk of contracting COVID-19 does not present an extraordinary and compelling reason for release when an inmate is offered the COVID-19 vaccine and refuses it, absent some medical contraindication. See, e.g., United States v. Ortiz, No. 18-cr-264, 2021 WL 1422816, at *3 (E.D. Pa. Apr. 15, 2021) (“[The defendant's] refusal to be vaccinated in the absence of a legitimate medical justification is fatal to his motion for compassionate release.”); United States v. Bautista, No. 19-cr-24, 2021 WL 1264596, at *5 (E.D. Pa. Apr. 6, 2021) (“[The defendant's] denial of the COVID-19 vaccine further weighs against...